Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Macaya Douoguih, Tamzin Tanner et al.|New England Journal of Medicine|2021Cited by 2.6k
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinCharles J. Fisher, Ernest Benjamin, Jan M. Agosti et al.|New England Journal of Medicine|1996Cited by 1.3k
Confirmatory interleukin-1 receptor antagonist trial in severe sepsisSteven M. Opal, Michael G. Seneff, Charles J. Fisher et al.|Critical Care Medicine|1997Cited by 863
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsisCharles J. Fisher, Jerald Sadoff, Steven M. Opal et al.|Critical Care Medicine|1993Cited by 431
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, Frank Tomaka et al.|The Lancet|2018Cited by 342